loanranger, IPIX investors are not focusing on who might have paid what for the R&D conducted by the RBL. Rather, we are focused on the that fact that it has been done, and look forward to the presentation on findings of the research beginning July 19 thru the 23rd at the 40th annual Society of Virology meeting that will a great deal of attention. They would not be presenting research on Brilacidin unless the result of the research was very positive.